WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel N. Swisher Jr.Director2025-04-102,200$70.22
$154.48kSell
Daniel N. Swisher Jr.Director2025-04-102,200$12.13
$26.69kBuy
William GuyerChief Development Officer2025-04-01678$114.51
$77.64kSell
Joseph Douglas LyonChief Accounting Technology Officer2025-04-01650$114.53
$74.44kSell
Joseph Douglas LyonChief Accounting Technology Officer2025-04-01650$13.56
$8.81kBuy
William GuyerChief Development Officer2025-04-01678$21.65
$14.68kBuy
Sean MaduckOfficer2025-04-01590$5.05
$2.98kBuy
Joseph K. BelanoffChief Executive Officer2025-04-01350$114.71
$40.15kSell
Sean MaduckOfficer2025-04-01590$114.55
$67.58kSell
Joseph K. BelanoffChief Executive Officer2025-03-3135,102$94.72
$3.32MSell

1 of 15

CORT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright42.47%44,802,403$2.79BInsider
Blackrock Inc14.86%15,677,327$975.76MInstitution
Bakker Juliet Tammenoms10.51%11,089,541$690.21MInsider
Longitude Venture Partners LP10.38%10,956,002$681.90MInsider
Vanguard Group Inc9.59%10,115,624$629.60MInstitution
Alta Biopharma Partners II LP9.46%9,982,720$621.32MInsider
G. Leonard Baker Jr.8.72%9,200,067$572.61MInsider
Ingalls Snyder LLC7.68%8,099,747$504.13MInstitution
Tench Coxe6.53%6,890,503$428.86MInsider
Joseph C. Cook Jr.6.41%6,765,805$421.10MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT30.22%69.78%Net BuyingNet Buying
MDGL25.70%74.30%Net SellingNet Buying
RVMD90.68%9.32%Net BuyingNet Selling
BBIO60.02%39.98%Net SellingNet Selling
HALO78.14%21.86%Net SellingNet Selling
View Top Biotech Stocks

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 79.83% institutional shareholders, 184.33% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 42.47% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $2.82B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.